Eulav Asset Management Amarin Corp Plcuk Transaction History

Eulav Asset Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$13.89 - $23.16 $24.2 Million - $40.3 Million	-1,740,000 Closed	0 $0
Q2 2019 Aug 05, 2019	BUY	$16.27 - $20.51 $3.09 Million - $3.9 Million	190,000 Added 12.26%	1,740,000 $33.7 Million
Q1 2019 May 13, 2019	BUY	$12.61 - $22.33 $5.67 Million - $10 Million	450,000 Added 40.91%	1,550,000 $31.2 Million
Q4 2018 Feb 14, 2019	BUY	$12.41 - $22.98 $1.86 Million - $3.45 Million	150,000 Added 15.79%	1,100,000 $15 Million
Q3 2018 Oct 26, 2018	BUY	$2.45 - $16.27 $2.33 Million - $15.5 Million	950,000 New	950,000 $15.5 Million

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $214M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Eulav Asset Management, based on Form 13F filings with the SEC.

Stay updated on Eulav Asset Management with notifications on news.